- Home
- QDEL
as of 12-10-2025 12:33pm EST
$28.45
+$1.01
+3.68%
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.
Chart Type:
Time Range:
| Founded: | 1979 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 1.7B | IPO Year: | N/A |
| Target Price: | $39.33 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Hold | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -17.44 | EPS Growth: | N/A |
| 52 Week Low/High: | $19.50 - $49.45 | Next Earning Date: | 11-05-2025 |
| Revenue: | $2,714,400,000 | Revenue Growth: | -3.67% |
| Revenue Growth (this year): | -0.68% | Revenue Growth (next year): | 2.42% |
AI-Powered QDEL Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 18 hours ago
AI Recommendation
hold
Model Accuracy: 73.29%
73.29%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of QuidelOrtho Corporation (QDEL)
Wilkins Joseph D Jr.
Buy
Director
QDEL Nov 26, 2025
Avg Cost/Share
$27.96
Shares
370
Total Value
$10,343.35
Owned After
11,876
SEC Form 4
WIDDER KENNETH J
Sell
Director
QDEL Nov 25, 2025
Avg Cost/Share
$27.81
Shares
4,026
Total Value
$111,965.48
Owned After
37,061
SEC Form 4
Busky Joseph M
Buy
Chief Financial Officer
QDEL Nov 24, 2025
Avg Cost/Share
$26.06
Shares
4,770
Total Value
$124,305.25
Owned After
6,920
SEC Form 4
POLAN MARY LAKE PH D
Buy
Director
QDEL Nov 21, 2025
Avg Cost/Share
$22.43
Shares
1,000
Total Value
$22,430.00
Owned After
12,640
SEC Form 4
Blaser Brian J
Buy
President and CEO
QDEL Nov 19, 2025
Avg Cost/Share
$21.34
Shares
23,500
Total Value
$501,576.95
Owned After
29,533
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Wilkins Joseph D Jr. | QDEL | Director | Nov 26, 2025 | Buy | $27.96 | 370 | $10,343.35 | 11,876 | |
| WIDDER KENNETH J | QDEL | Director | Nov 25, 2025 | Sell | $27.81 | 4,026 | $111,965.48 | 37,061 | |
| Busky Joseph M | QDEL | Chief Financial Officer | Nov 24, 2025 | Buy | $26.06 | 4,770 | $124,305.25 | 6,920 | |
| POLAN MARY LAKE PH D | QDEL | Director | Nov 21, 2025 | Buy | $22.43 | 1,000 | $22,430.00 | 12,640 | |
| Blaser Brian J | QDEL | President and CEO | Nov 19, 2025 | Buy | $21.34 | 23,500 | $501,576.95 | 29,533 |
Latest QuidelOrtho Corporation News
QDEL Breaking Stock News: Dive into QDEL Ticker-Specific Updates for Smart Investing
Compare QDEL vs Leading Stocks
See how QDEL stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "QDEL QuidelOrtho Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.